Libster D - Search Results

1

Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.

Shaulov A, Ganzel C, Benyamini N, Barshay Y, Goldschmidt N, Lavie D, Libster D, Gural A, Avni B, Gatt ME. Shaulov A, et al. Among authors: libster d. Am J Hematol. 2017 Feb;92(2):131-135. doi: 10.1002/ajh.24596. Epub 2016 Nov 21. Am J Hematol. 2017. PMID: 27804150 Free article.

2

A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.

Dann EJ, Blumenfeld Z, Bar-Shalom R, Avivi I, Ben-Shachar M, Goor O, Libster D, Gaitini D, Rowe JM, Epelbaum R. Dann EJ, et al. Among authors: libster d. Am J Hematol. 2012 Jan;87(1):32-6. doi: 10.1002/ajh.22187. Epub 2011 Sep 28. Am J Hematol. 2012. PMID: 21956220 Free article.

3

Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia.

Vine J, Cohen SB, Ruchlemer R, Goldschmidt N, Levin M, Libster D, Gural A, Gatt ME, Lavie D, Ben-Yehuda D, Rund D. Vine J, et al. Among authors: libster d. Leuk Lymphoma. 2014 Nov;55(11):2525-31. doi: 10.3109/10428194.2014.893307. Epub 2014 Mar 19. Leuk Lymphoma. 2014. PMID: 24524306

4

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

Goldschmidt N, Kleinstern G, Orevi M, Paltiel O, Ben-Yehuda D, Gural A, Libster D, Lavie D, Gatt ME. Goldschmidt N, et al. Among authors: libster d. Cancer Chemother Pharmacol. 2016 May;77(5):1053-60. doi: 10.1007/s00280-016-3024-8. Epub 2016 Apr 7. Cancer Chemother Pharmacol. 2016. PMID: 27056383

5

Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis.

Pick M, Vainstein V, Goldschmidt N, Lavie D, Libster D, Gural A, Grisariu S, Avni B, Ben Yehuda D, Gatt ME. Pick M, et al. Among authors: libster d. Eur J Haematol. 2018 May;100(5):494-501. doi: 10.1111/ejh.13046. Epub 2018 Mar 25. Eur J Haematol. 2018. PMID: 29453884

6

Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.

Beyar Katz O, Perry C, Grisariu-Greenzaid S, Yehudai-Ofir D, Luttwak E, Avni B, Zuckerman T, Sdayoor I, Stepensky P, Ringelstein-Harlev S, Bar-On Y, Libster D, Sharvit L, Amit O, Greenbaum U, Gold R, Herishanu Y, Benyamini N, Avivi I, Ram R. Beyar Katz O, et al. Among authors: libster d. Eur J Haematol. 2023 Jul;111(1):63-71. doi: 10.1111/ejh.13968. Epub 2023 Apr 10. Eur J Haematol. 2023. PMID: 36964939

7

Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.

Aumann S, Tsubary U, Nachmias B, Ben Yehuda D, Lavie D, Goldschmidt N, Vainstein V, Libster D, Saban R, Shaulov A, Israel S, Avni B, Grisariu S, Bdolah-Amram T, Gatt M, Zimran E. Aumann S, et al. Among authors: libster d. Eur J Haematol. 2023 Jul;111(1):135-145. doi: 10.1111/ejh.13977. Epub 2023 Apr 24. Eur J Haematol. 2023. PMID: 37096337

8

Large B-cell lymphoma manifesting as an invasive cardiac mass: sustained local remission after combination of methotrexate and rituximab.

Cohen Y, Daas N, Libster D, Gillonb D, Polliack A. Cohen Y, et al. Among authors: libster d. Leuk Lymphoma. 2002 Jul;43(7):1485-7. doi: 10.1080/1042819022386699. Leuk Lymphoma. 2002. PMID: 12389634

9

Bleeding, obstruction, and perforation in a series of patients with aggressive gastric lymphoma treated with primary chemotherapy.

Spectre G, Libster D, Grisariu S, Da'as N, Yehuda DB, Gimmon Z, Paltiel O. Spectre G, et al. Among authors: libster d. Ann Surg Oncol. 2006 Nov;13(11):1372-8. doi: 10.1245/s10434-006-9069-x. Epub 2006 Sep 30. Ann Surg Oncol. 2006. PMID: 17009162

10

Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab-containing regimens: natural history- or therapy-related complication?

Cohen Y, Da'as N, Libster D, Amir G, Berrebi A, Polliack A. Cohen Y, et al. Among authors: libster d. Eur J Haematol. 2002 Feb;68(2):80-3. doi: 10.1034/j.1600-0609.2002.01599.x. Eur J Haematol. 2002. PMID: 12038452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page